# 119-hr-1414: Cameron’s Law

119-hr-1414, Cameron’s Law, is a 119th Congress bill sponsored by Rep. Gottheimer, Josh [D-NJ-5] (D-NJ); status introduced; PRIA reads it as touching household money (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-1414
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-1414
- Congress: 119
- Title: Cameron’s Law
- Status: introduced
- Introduced: 2025-02-18
- Sponsor: Rep. Gottheimer, Josh [D-NJ-5] (D-NJ)
- Cosponsors: 19
- Policy area: Taxation
- Touches household money: yes
- Last recorded action: 2026-09-21

## Summary

**Doubles the orphan drug tax credit to 50%** so eligible taxpayers would get a larger tax offset for qualifying orphan drug costs. The bill would amend Section 45C(a) of the Internal Revenue Code by replacing the current 25% credit rate with a 50% rate. This change would apply to taxable years beginning after enactment. The text does not alter eligibility rules, definitions, administration, or enforcement for the credit. The direct effect is to increase the tax credit available for qualified orphan drug expenditures.

## Cosponsors (19)

- Rep. Bacon, Don [R-NE-2] (R-NE), 2025-02-18T00:00:00.000Z
- Rep. Panetta, Jimmy [D-CA-19] (D-CA), 2025-02-18T00:00:00.000Z
- Rep. Suozzi, Thomas R. [D-NY-3] (D-NY), 2025-02-18T00:00:00.000Z
- Rep. Miller, Max L. [R-OH-7] (R-OH), 2025-02-25T00:00:00.000Z
- Rep. Fitzpatrick, Brian K. [R-PA-1] (R-PA), 2025-02-26T00:00:00.000Z
- Rep. Carey, Mike [R-OH-15] (R-OH), 2025-03-24T00:00:00.000Z
- Rep. Johnson, Henry C. "Hank" [D-GA-4] (D-GA), 2025-04-07T00:00:00.000Z
- Rep. Davis, Donald G. [D-NC-1] (D-NC), 2025-04-10T00:00:00.000Z
- Rep. Lawler, Michael [R-NY-17] (R-NY), 2025-07-10T00:00:00.000Z
- Rep. Cuellar, Henry [D-TX-28] (D-TX), 2025-08-08T00:00:00.000Z
- Rep. Schneider, Bradley Scott [D-IL-10] (D-IL), 2025-09-15T00:00:00.000Z
- Rep. Costa, Jim [D-CA-21] (D-CA), 2025-09-30T00:00:00.000Z
- Rep. Kim, Young [R-CA-40] (R-CA), 2025-10-21T00:00:00.000Z
- Rep. Kelly, Mike [R-PA-16] (R-PA), 2025-10-24T00:00:00.000Z
- Rep. Carson, André [D-IN-7] (D-IN), 2025-11-18T00:00:00.000Z
- Rep. Tenney, Claudia [R-NY-24] (R-NY), 2025-12-02T00:00:00.000Z
- Rep. Kiggans, Jennifer A. [R-VA-2] (R-VA), 2026-04-29T00:00:00.000Z
- Rep. Kean, Thomas H. [R-NJ-7] (R-NJ), 2026-05-12T00:00:00.000Z
- Rep. Hurd, Jeff [R-CO-3] (R-CO), 2026-06-03T00:00:00.000Z

## Provisions PRIA read

- Bigger tax credit for rare-disease drugs: benefit, high. If enacted, companies that develop drugs for rare diseases could get a larger tax credit. The credit rate would rise from 25% to 50% of qualifying spending. It would apply to taxable years that begin after the bill is enacted. The bill does not change who can claim the credit.

## Related bills

- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-2102: Major Richard Star Act
- 119-hr-4206: CONNECT for Health Act of 2025
- 119-hr-1065: Protect Our Letter Carriers Act of 2025
- 119-hr-979: AM Radio for Every Vehicle Act of 2025

## Sources
- [119-hr-1414 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/1414)

## Related
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-2102: Major Richard Star Act](https://policyrisk.com/legislation/119-hr-2102)
- [119-hr-4206: CONNECT for Health Act of 2025](https://policyrisk.com/legislation/119-hr-4206)
- [119-hr-1065: Protect Our Letter Carriers Act of 2025](https://policyrisk.com/legislation/119-hr-1065)
- [119-hr-979: AM Radio for Every Vehicle Act of 2025](https://policyrisk.com/legislation/119-hr-979)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-1414 (as of 2026-09-21).
